ELVN Competitors & Alternatives
Compare Enliven Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ELVN
Main Stock$45.10
Tradestie Score
59
Market Cap
$1.17B
Analyst Upside
+33.3%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
QURE
uniQure N.V.
|
$46.29
|
$3.39B | - | 57 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$47.33
|
$3.33B | - | 61 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$29.83
|
$3.31B | - | 50 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$24.63
|
$3.09B | - | 53 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$30.38
|
$3.08B | - | 54 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.02
|
$3.03B | - | 60 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$52.91
|
$3.02B | - | 65 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$61.08
|
$3.01B | - | 55 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
More ELVN Analysis
Data updated: Jun 21, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry